Enhancement of the Soluble Form of OX40 and OX40L Costimulatory Molecules but Reduction of the Membrane Form in Type 1 Diabetes (T1D)

Table 2

Correlation between clinical features and membrane levels of OX40 and OX40L.

	CD4^+OX40^+		CD8^+OX40^+		CD3^+OX40^+		CD19^+OX40L^+		CD14^+OX40L^+
	Ketosis	0.2692	0.2257	0.1746	0.4301	0.2770	0.2121	-0.3000	0.1750	0.1307	0.5619
GAD	-0.0570	0.7818	-0.3996	0.0431	-0.0571	0.7816	-0.3789	0.0463	-0.1401	0.4948
ICA	-0.0121	0.9529	-0.1582	0.4401	-0.0365	0.8593	-0.0608	0.7677	0.1245	1.0042
IAA	0.1467	0.4746	-0.1467	0.4746	0.1735	0.3968	-0.0133	0.9485	-0.0933	0.6502
DKA	0.4468	0.0371	0.1043	0.6443	0.3725	0.0878	-0.0744	0.7419	-0.0148	0.9475
HDL	-0.3474	0.0555	-0.2594	0.1588	-0.3528	0.0516	-0.1488	0.4245	-0.1671	0.3689
LDL	-0.1773	0.3401	-0.1264	0.4979	-0.2231	0.2276	-0.1470	0.4300	-0.1408	0.4501
TC	-0.2280	0.2019	-0.2848	0.1081	-0.2739	0.1230	-0.1321	0.4638	-0.1053	0.5597
TG	0.3627	0.0380	0.0844	0.6404	0.2936	0.0973	0.2199	0.2189	0.1634	0.3637
ALT	-0.0560	0.7605	0.1015	0.5804	0.0540	0.7688	0.0421	0.8190	0.1166	0.5252
AST	0.0852	0.6426	0.2025	0.2663	0.2056	0.2591	0.0343	0.8519	0.0479	0.7943
LDH	0.0260	0.9107	0.0655	0.9978	0.1383	0.5500	0.0416	0.8576	0.1498	0.5168
GGT	-0.0510	0.8085	0.1969	0.3455	-0.1076	0.6086	0.0947	0.6522	-0.3137	0.1267
Cr	-0.4072	0.0187	-0.1674	0.9926	-0.3911	0.0244	0.0363	0.8410	-0.2899	0.1017
BUN	-0.2858	0.1069	-0.1345	0.4557	-0.2436	0.1719	0.1462	0.4170	-0.1055	0.5589
UA	-0.4231	0.0142	-0.6887	0.7033	-0.4357	0.0113	0.0885	0.6239	-0.3246	0.0653
GLU	0.1162	0.5802	-0.4501	0.8308	0.1328	0.5268	0.0076	0.9971	-0.0561	0.7897
C0	-0.1418	0.4238	-0.1189	0.5031	-0.2069	0.2404	-0.0207	0.9072	0.1722	0.3300
C120	-0.2638	0.2901	-0.1209	0.6328	-0.3487	0.1562	0.0830	0.7432	0.3595	0.1429
HbA1c	0.4666	0.0047	0.0926	0.5966	0.3930	0.0195	0.3994	0.0175	0.3332	0.0504